[1]
“ Randomized double-blind clinical trial of a new human epoetin versus a commercially available formula for anemia control in patients on hemodialysis ”, Clinics, vol. 69, no. 8, pp. 547–553, Aug. 2014, doi: 10.6061/clinics/2014(08)08.